++
This chapter will be most useful after having a basic understanding of the material in Chapter 21, Pharmacotherapy of the Epilepsies in Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 12th Edition. In addition to the material presented here, the 12th Edition includes:
++
A detailed discussion of the nature and mechanisms of seizures, including models of epilepsy
A discussion of the genetic approaches to the epilepsies
The structures of the antiseizure drugs
A detailed discussion of the general principles that determine the choice of drugs for therapy of the epilepsies
++
Know the different seizure types and the mechanisms that are responsible for each type.
Understand the mechanisms of action of the antiseizure drugs and how they are used to treat the different types of seizures.
Describe the toxicities, adverse effects, and salient drug interactions of drugs used to treat the epilepsies.
Know the general principles of drug therapy of the epilepsies.
++
DRUGS INCLUDED IN THIS CHAPTER
Acetazolamide (DIAMOX, others)
Carbamezepine (TEGRETOL, CARBATROL, others)
Clonazepam (KLONOPIN, others)
Clorazepate (TRANXENE, others)
Ethosuximide (ZARONTIN, others)
Felbamate (FELBATOL)—withdrawn from market
Fosphenytoin (CEREBYX, others)
Gabapentin (NEURONTIN, others)
Lacosamide (VIMPAT)
Lamotrigine (LAMICTAL, others)
Levetiracetam (KEPPRA, others)
Methsuximide (CELONTIN)
Oxcarbazepine (TRILEPTAL, others)
Phenobarbital (LUMINAL, others)
Phenytoin (DILANTIN, others)
Pregabalin (LYROCA, others)
Rufinamide (BANZEL)
Tiagabine (GABITRIL)
Topiramate (TOPAMAX, others)
Valproic acid (DEPAKENE, others)
Vigabatrin (SABRIL)
Zonisamide (ZONEGRAN, others)
++